Partners AMR Insights

For its global activities AMR Insights is dependent on its highly valued partners.

Our current partners:

The NIH NIAID program, “Chemistry Center for Combatting Antibiotic Resistant Bacteria” (CC4CARB) is an innovative chemistry center focused on the synthesis and delivery of rationally designed, focused libraries for the scientific community to use in Gram-negative antibacterial drug discovery. The ultimate objective of CC4CARB is to create a large collection of chemical matter specifically targeting Gram-negative threats.

NIAID and RTI welcome you to participate in CC4CARB as we are currently accepting scaffold proposals. Additional information on CC4CARB can be found on the program website.



Evotec provides a comprehensive suite of integrated capabilities for drug discovery and development to solve problems, create inventive step and deliver success as quickly as possible for our partners through highest quality science, knowledge, technology and operational excellence.



Addressing the human health impacts of AMR will require building a strong and motivated coalition of like-minded health officials, clinicians, laboratorians, policymakers, patients and leaders.



NYtor (2007) designs and (co-)develops smart, molecular assays for detecting antibiotic resistance in human and veterinary diagnostics. Design and co-development take place in close collaboration with customers, selected suppliers and global partners. NYtor also produces its prototype assays.



To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!